Im­mu­no­lo­gi­cal phe­no­me­nons in the pa­tho­lo­gy of the te­ar film. Is cyc­lo­spo­ri­ne the turn po­int in the Sjögren’s syn­dro­me tre­at­ment? Pre­li­mi­na­ry re­port

Purpose
The purpose of this study is to examine the new way in the casual treatment, resulting in the normalization of immunological processes on the ocular surface.

Material and methods
5 patients (4 women and 1 men with mean age of 55,5 years, range 45 to 59 years) with Sjögren’s syndrome – type dry eye, were included in the study. Patients received topically 0,05% cyclosporine, ophthalmic emulsion twice a day for a 6 months. The severity of patients complaints was evaluated according to the Dr. Mann Pharma / Bausch & Lomb’s record.

Results
Schirmer test II values, and lyzamine green staining scores, were evaluated priori to treatment and 6 months after the start. At the beginning of the study (day 0) the Schirmer test II values ranged from 1 to 5 mm (mean – 2,2 mm). Break-up-time ranged from 3 to 6 sec (mean – 4,8 sec). In all of 5 cases lyzamine green staining scores were 9. On month 6th, all of 5 patients had significant differences, compared to their baseline measurements in term of above mentioned parameters. The Schirmer test II values ranged from 8 to 12 mm (mean – 10,3 mm). Break-up-time ranged from 9 to 13 sec (mean – 11,2 sec), lyzamine green staining scores ranged from 2 to 3 points (mean – 2,7).

Conclusions
0,05% cyclosporine, ophthalmic emulsion had a beneficial effect both on the subjective and objective clinical parameters of dry eye patients. The final conclusions must be supported by more cases.